Skip to main content
. 2021 Apr 9;8:603501. doi: 10.3389/fcvm.2021.603501

Table 4.

Univariate and multivariate analysis of the stroke, bleeding, and other endpoints.

Clinical outcomes Univariate Multivariate
OR 95% CI P-value OR 95% CI P-value
Primary endpoint
Stroke history 3.000 1.063~8.468 0.038 3.000 1.063~8.468 0.038
SEC 3.032 1.011~9.098 0.048
Stroke events
Platelet count 1.015 1.002~1.029 0.022 1.015 1.002~1.029 0.022
DRT
Platelet count 1.014 1.001~1.027 0.032
Stroke history 11.583 1.263~106.198 0.030 23.509 1.261~438.351 0.023
PDL 8.467 0.926~77.389 0.058 17.005 1.008~286.902 0.049
LAA flow velocity 0 0~0.073 0.025
Overall bleeding events
Platelet count 0.990 0.980~1.000 0.041
Thrombocytopenia 6.330 2.172~18.471 0.001 8.150 2.579~25.757 <0.001
HAS-BLED score 1.957 1.129~3.392 0.017 2.307 1.254~4.243 0.007
Bleeding history 3.311 1.111~9.868 0.032
Major bleeding
HAS-BLED 2.200 1.107~4.373 0.024 2.441 1.177~5.061 0.016
Thrombocytopenia 3.667 0.972~13.832 0.055 4.571 1.133~18.438 0.033

SEC, spontaneous echo contrast; DRT, device-related thrombus; PDL, peri-device leak; LAA, left atrial appendage.